| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 10 |
| 1 | FLUOROURACIL CREAM, 0.5% | 10 |
| 2 | OXALIPLATIN | 8 |
| 3 | BEVACIZUMAB | 7 |
| 4 | ATEZOLIZUMAB | 4 |
| 5 | CARVEDILOL | 4 |
| 6 | CAPECITABINE | 3 |
| 7 | METHOTREXATE SODIUM | 3 |
| 8 | ACETAMINOPHEN | 2 |
| 9 | ACETAMINOPHEN 500MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 1 | 0.0009 |
| 1 | SODIUM FERRIC GLUCONATE COMPLEX | 1 | 0.0005 |
| 2 | RILUZOLE | 1 | 0.0004 |
| 3 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 4 | ZINC SULFATE INJECTION, | 1 | 0.0003 |
| 5 | ZINC SULFATE INJECTION | 1 | 0.0003 |
| 6 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 7 | MIDODRINE HYDROCHLORIDE | 1 | 0.0002 |
| 8 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 9 | FLUOROURACIL CREAM, 0.5% | 10 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Benzothiazole [EPC] | 1 | 0.0004 |
| 1 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 2 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 4 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 6 | Rifamycin Antibacterial [EPC] | 2 | 0.0001 |
| 7 | Hepatitis C Virus NS5A Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 11 | 0.0000 |